Status | Study |
Recruiting |
Study Name: Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders Condition: Primary Biliary Cirrhosis Date: 2016-10-13 Interventions: Drug: Bezafibrate Bezafibrate |
Active, not recruiting |
Study Name: The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland Condition: Primary Biliary Cirrhosis Date: 2016-07-25 |
Recruiting |
Study Name: Phase 3 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cirrhosis Condition: Liver Cirrhosis, Biliary Date: 2014-11-10 Interventions: Drug: Obeticholic Acid (OCA) |
Active, not recruiting |
Study Name: Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis Condition: Primary Biliary Cirrhosis Date: 2014-03-03 Interventions: Biological: abatacept 125 mg subcutaneously each week for 24 weeks |
Completed |
Study Name: Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis Condition: Primary Biliary Cirrhosis Date: 2013-05-16 Interventions: Drug: Tauroursodeoxycholic Acid Capsules |
Active, not recruiting |
Study Name: Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis Condition: Primary Biliary Cirrhosis Date: 2012-08-05 Interventions: Other: conventional plus UC-MSC treatment |
Active, not recruiting |
Study Name: Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis Condition: Primary Biliary Cirrhosis Date: 2011-11-14 Interventions: Drug: Obeticholic Acid (OCA) O |
Completed |
Study Name: Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis Condition: Primary Biliary Cirrhosis Date: 2011-09-20 Interventions: Biological: Biological: mesenchymal stem cell |
Completed |
Study Name: A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid Condition: Primary Biliary Cirrhosis Date: 2011-07-07 Interventions: Drug: ustekinumab 90 mg Subcut |
Completed |
Study Name: Pentoxifylline for Primary Biliary Cirrhosis Condition: Primary Biliary Cirrhosis Date: 2010-11-24 Interventions: Drug: Pentoxifylline Patients will take 400mg of pentoxifylline three times daily for a total duration o |